229 related articles for article (PubMed ID: 26417876)
21. Does everolimus associated with a low dose of cyclosporine in long-term cardiac transplant recipients improve renal function? Initial experience.
Boffini M; Sansone F; Patanè F; Bonato R; Ribezzo M; Iacovino C; Comoglio C; Rinaldi M
Transplant Proc; 2009 May; 41(4):1349-52. PubMed ID: 19460557
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of chronic kidney disease is extremely high in heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2009 Oct; 41(8):3239-41. PubMed ID: 19857720
[TBL] [Abstract][Full Text] [Related]
23. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
Garrido IP; Crespo-Leiro MG; Paniagua MJ; Muñiz J; Vázquez-Rey E; Pérez-Fernández R; García-Lara J; Cuenca-Castillo JJ; Castro-Beiras A
J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
[TBL] [Abstract][Full Text] [Related]
24. Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation.
Tan HK; Marquez M; Wong F; Renner EL
Transplantation; 2015 Jul; 99(7):1441-6. PubMed ID: 25643142
[TBL] [Abstract][Full Text] [Related]
25. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
26. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
Issa N; Kukla A; Ibrahim HN
Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509
[TBL] [Abstract][Full Text] [Related]
27. Calcineurin inhibitors in heart transplantation.
Keogh A
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
[TBL] [Abstract][Full Text] [Related]
28. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
[TBL] [Abstract][Full Text] [Related]
29. Transplantation: impact of pretransplant renal insufficiency.
Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
[TBL] [Abstract][Full Text] [Related]
30. Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients.
Chinnock TJ; Shankel T; Deming D; Cutler D; Sahney S; Fitts J; Chinnock RE
Pediatr Transplant; 2011 Nov; 15(7):746-9. PubMed ID: 21883751
[TBL] [Abstract][Full Text] [Related]
31. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.
Zawiasa A; Nowicki M
Metabolism; 2013 Oct; 62(10):1462-9. PubMed ID: 23866980
[TBL] [Abstract][Full Text] [Related]
32. Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patients.
Grinyo JM; Saval N; Campistol JM;
Nephrol Dial Transplant; 2011 Nov; 26(11):3750-5. PubMed ID: 21474575
[TBL] [Abstract][Full Text] [Related]
33. Chronic kidney disease after heart transplantation.
Hamour IM; Omar F; Lyster HS; Palmer A; Banner NR
Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463
[TBL] [Abstract][Full Text] [Related]
34. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
Brann WM; Bennett LE; Keck BM; Hosenpud JD
J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
[TBL] [Abstract][Full Text] [Related]
36. [Effect of hypertension on the renal and cardiac functions of patients with heart transplantation].
Farge D; Julien J; Amrein C; Guillemain R; Vulser C; Mihaileanu S; Dreyfus G; Couetil JP; Carpentier A
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1129-33. PubMed ID: 2148070
[TBL] [Abstract][Full Text] [Related]
37. Renal-sparing strategies in cardiac transplantation.
Gustafsson F; Ross HJ
Curr Opin Organ Transplant; 2009 Oct; 14(5):566-70. PubMed ID: 19542890
[TBL] [Abstract][Full Text] [Related]
38. Risk of stroke in kidney disease.
Ninomiya T
Contrib Nephrol; 2013; 179():58-66. PubMed ID: 23652449
[TBL] [Abstract][Full Text] [Related]
39. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
[TBL] [Abstract][Full Text] [Related]
40. Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.
Oetjens M; Bush WS; Birdwell KA; Dilks HH; Bowton EA; Denny JC; Wilke RA; Roden DM; Crawford DC
Pac Symp Biocomput; 2014; ():253-64. PubMed ID: 24297552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
